May 1, 2024, 08:29 AM by

Supply chain resilience and new partner sourcing to benefit from a boom in outsourcing in 2025

May 1, 2024, 08:29 AM by

May 1, 2024, 08:29 AM by

Lonza customers can now access TriLink’s CleanCap® mRNA capping technology for non-commercial use, enabling further development of critical mRNA therapeutics.

May 1, 2024, 06:00 AM by User Not Found

Bio-IT World | Researchers in Denmark have devised a blood-based diagnostic technique that can detect even trace amounts of an aggregated protein indicative of Alzheimer’s disease before any disease-related changes show up on a PET scan, one of the traditional testing methods.

Apr 30, 2024, 06:10 AM by

Watson-Marlow Fluid Technology Solutions (WMFTS) has advanced DriveSure® with the latest technology to offer a complete peristaltic panel mount pump solution for original equipment manufacturers (OEMs).

Apr 30, 2024, 06:00 AM by User Not Found

Bio-IT World | Last week, Steve Pagliuca was flying to Milan to catch an Atalanta football match, an Italian professional football club of which he is part owner. But before his flight, he stopped to talk biotech at the Bio-IT World Venture, Innovation & Partnering Conference held in conjunction with the Bio-IT World Conference & Expo.

Apr 29, 2024, 08:58 AM by

Apr 29, 2024, 08:58 AM by

Apr 25, 2024, 08:17 AM by

Apr 25, 2024, 08:17 AM by

Apr 25, 2024, 08:16 AM by

Model Medicines has appointed Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor. With over 25 years of leadership experience in the life sciences industry, Dr. Aspeslet will provide strategic guidance to support the company's growth and advance its pipeline of novel therapeutics. Her appointment comes as Model Medicines announces the "AI Pharma Code," a set of criteria that includes identifying novel biology, new chemical entities, high zero-shot hit rates, low Tanimoto scores, a diverse pipeline across biology and disease, and preclinical proof of concept. Dr. Aspeslet's expertise will be invaluable to Model Medicines' mission to revolutionize drug discovery and development.

Apr 25, 2024, 06:00 AM by User Not Found

Bio-IT World | Ginkgo Bioworks has expanded its strategic partnership with Novo Nordisk; Mission Bio introduced sample multiplexing features for the company’s Tapestri Platform; PathAI announced a strategic partnership with Google Cloud at Bio-IT World Conference & Expo to help biopharma companies and anatomic pathology labs accelerate the adoption of AI and digital pathology; more.

Apr 24, 2024, 09:15 AM by

atson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range at the Water Equipment Show hosted in Telford, UK, on 16th May.

Apr 24, 2024, 09:15 AM by

Advancing diagnosis and research with an enterprise software platform

Apr 24, 2024, 09:15 AM by

Novel Concepts Medical’s case study shows improvement in a colon cancer patient with metastases in his liver and shrinkage of his tumor size after using our plant-based treatment.

Apr 24, 2024, 09:15 AM by

https://www.prnewswire.com/news-releases/community-health-network-selects-biofourmis-to-help-drive-care-at-home-outcomes-across-the-continuum-302124335.html?tc=eml_cleartime

Apr 24, 2024, 09:15 AM by

Clarapath forms strategic collaboration with Mayo Clinic to advance pathology tissue processing. Robotics, AI and automation help improve patient outcomes and solve laboratory labor shortages.

Apr 24, 2024, 09:15 AM by

https://www.prnewswire.com/news-releases/drfirst-and-patchrx-partnership-combines-medication-history-with-daily-patient-adherence-data-302124060.html?tc=eml_cleartime

Apr 24, 2024, 06:00 AM by User Not Found

Bio-IT World | Seaport Therapeutics plans to advance their Glyph platform, which leverages the lymphatic system to create new medicines building on clinically validated mechanisms and has demonstrated clinical proof-of-concept; Nectero Medical will accelerate the execution of the Phase II/III (stAAAble) trial and to support the submission of a New Drug Application with the U.S. Food and Drug Administration for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST) System; DeepCure will further develop its generative AI and physics-based engine to innovate the discovery of small molecule therapies for challenging targets; more.

Apr 23, 2024, 06:23 AM by

This brand relaunch emphasizes a focus on building emerging life science and biopharma brands with complementary client offerings as part of the larger CG Life platform.